FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

KREBSBIO

73.65
-0.7 (-0.94%)
Updated 03:28 13/07 IST

KREBSBIO Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for KREBSBIO
Disclaimer
0% Bullish
0% Bearish

KREBSBIO Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See KREBSBIO Share Price Targets >>

KREBSBIO Ratings

Long term KREBSBIO rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live KREBSBIO message board: Is KREBSBIO buy or sell? Should I buy KREBSBIO shares? Why are KREBSBIO shares falling? Should I invest in KREBSBIO stock?

  1. Home
  2. KREBSBIO Forum

KREBSBIO Share Price Discussion

Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • KREBSBIO - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization192.91
    Enterprise Value225.82
    Price to Earnings13.38
    Price to Book Value93.58
    Return on Capital Employed-0.33
    Return on Equity1
    Face Value10
    Dividend YieldNA
  • KREBSBIO Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 1375.057672.873.1
    Jul 1072.257671.1574.35
    Jul 875.1576.7572.373.45
    Jul 772.1577.9571.175.15
    Jul 673.357571.8573.1
  • KREBSBIO Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹77.63
    30 Day Moving Average₹79.33
    50 Day Moving Average₹77.02
    100 Day Moving Average₹79.62
    200 Day Moving Average₹83.69
  • KREBSBIO - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue33.813.269.37
    Operating Profit-8.86-8.80.01
    Profit Before Tax-17.83-16.050.11
    Net Income-17.82-16.050.11
  • KREBSBIO - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds-14.29-17.78-0.2
    Total Liabilities156.66143.660.09
    Total Assets142.37125.880.13
  • KREBSBIO - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity-7.15-11.2-0.36
    Cash from Investing Activity-1.48-4.7-0.69
    Cash from Financing Activity8.9315.75-0.43
    Net Cash Flow0.3-0.15-3
  • KREBSBIO - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets-0.14-0.13
    Return on Equity1-10.92
    Return on Capital Employed-0.33-0.26
  • KREBSBIO - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.99
    3 Year CAGR Growth in Operating Profit-3.54
    3 Year CAGR Growth in EBIDTA-3.38
    3 Year CAGR Growth in Net Income-1.27
    3 Yr CAGR Growth - Diluted EPS-0.57
  • KREBSBIO - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.95
    5 Year CAGR Growth in Operating Profit0.33
    5 Year CAGR Growth in EBIDTA-0.21
    5 Year CAGR Growth in Net Income-0.17
    3 Yr CAGR Growth - Diluted EPS0.19
  • KREBSBIO - Recent News

    keyboard_arrow_down
  • KREBSBIO - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020